Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multimodal mapping of the tumor and peripheral blood immune landscape in human pancreatic cancer
Nina G. Steele, Eileen S. Carpenter, Samantha B. Kemp, et al.
Nature Cancer (2020) Vol. 1, Iss. 11, pp. 1097-1112
Open Access | Times Cited: 359

Showing 1-25 of 359 citing articles:

Systemic immunity in cancer
Kamir J. Hiam-Galvez, Breanna M. Allen, Matthew H. Spitzer
Nature reviews. Cancer (2021) Vol. 21, Iss. 6, pp. 345-359
Open Access | Times Cited: 976
Pancreatic cancer: Advances and challenges
Christopher J. Halbrook, Costas A. Lyssiotis, Marina Pasca di Magliano, et al.
Cell (2023) Vol. 186, Iss. 8, pp. 1729-1754
Open Access | Times Cited: 554
Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity
Kebria Hezaveh, Rahul Shinde, Andreas Klötgen, et al.
Immunity (2022) Vol. 55, Iss. 2, pp. 324-340.e8
Open Access | Times Cited: 359
Macrophage diversity in cancer revisited in the era of single-cell omics
Ruoyu Ma, Annabel Black, Bin‐Zhi Qian
Trends in Immunology (2022) Vol. 43, Iss. 7, pp. 546-563
Open Access | Times Cited: 355
Spatially confined sub-tumor microenvironments in pancreatic cancer
Barbara T. Grünwald, Antoine Devisme, Geoffroy Andrieux, et al.
Cell (2021) Vol. 184, Iss. 22, pp. 5577-5592.e18
Open Access | Times Cited: 281
Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity
Colin Hutton, Felix Heider, Adrián Blanco‐Gómez, et al.
Cancer Cell (2021) Vol. 39, Iss. 9, pp. 1227-1244.e20
Open Access | Times Cited: 242
Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment
William L. Hwang, Karthik A. Jagadeesh, Jimmy A. Guo, et al.
Nature Genetics (2022) Vol. 54, Iss. 8, pp. 1178-1191
Open Access | Times Cited: 231
Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer
Nina G. Steele, Giulia Biffi, Samantha B. Kemp, et al.
Clinical Cancer Research (2021) Vol. 27, Iss. 7, pp. 2023-2037
Open Access | Times Cited: 213
Hallmarks of transcriptional intratumour heterogeneity across a thousand tumours
Avishai Gavish, Michael Tyler, Alissa C. Greenwald, et al.
Nature (2023) Vol. 618, Iss. 7965, pp. 598-606
Closed Access | Times Cited: 213
Tumor Microenvironment in Pancreatic Cancer Pathogenesis and Therapeutic Resistance
Mara H. Sherman, Gregory L. Beatty
Annual Review of Pathology Mechanisms of Disease (2022) Vol. 18, Iss. 1, pp. 123-148
Open Access | Times Cited: 206
T cell characteristics associated with toxicity to immune checkpoint blockade in patients with melanoma
Alexander X. Lozano, Aadel A. Chaudhuri, Aishwarya Nene, et al.
Nature Medicine (2022) Vol. 28, Iss. 2, pp. 353-362
Open Access | Times Cited: 204
Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance
Xiaowei Liu, Jinen Song, Hao Zhang, et al.
Cancer Cell (2023) Vol. 41, Iss. 2, pp. 272-287.e9
Open Access | Times Cited: 189
The CD155/TIGIT axis promotes and maintains immune evasion in neoantigen-expressing pancreatic cancer
William A. Freed-Pastor, Laurens J. Lambert, Zackery A. Ely, et al.
Cancer Cell (2021) Vol. 39, Iss. 10, pp. 1342-1360.e14
Open Access | Times Cited: 188
Neoadjuvant PD-1 blockade induces T cell and cDC1 activation but fails to overcome the immunosuppressive tumor associated macrophages in recurrent glioblastoma
Alex Lee, Lu Sun, Aaron Mochizuki, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 161
Single-cell RNA-seq analysis reveals BHLHE40-driven pro-tumour neutrophils with hyperactivated glycolysis in pancreatic tumour microenvironment
Liwen Wang, Yihao Liu, Yuting Dai, et al.
Gut (2022) Vol. 72, Iss. 5, pp. 958-971
Open Access | Times Cited: 147
Deterministic reprogramming of neutrophils within tumors
Melissa Ng, Immanuel Kwok, Leonard Tan, et al.
Science (2024) Vol. 383, Iss. 6679
Open Access | Times Cited: 130
Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer
Katelyn T. Byrne, Courtney B. Betts, Rosemarie Mick, et al.
Clinical Cancer Research (2021) Vol. 27, Iss. 16, pp. 4574-4586
Open Access | Times Cited: 129
Apolipoprotein E Promotes Immune Suppression in Pancreatic Cancer through NF-κB–Mediated Production of CXCL1
Samantha B. Kemp, Eileen S. Carpenter, Nina G. Steele, et al.
Cancer Research (2021) Vol. 81, Iss. 16, pp. 4305-4318
Open Access | Times Cited: 127
Leukocyte Heterogeneity in Pancreatic Ductal Adenocarcinoma: Phenotypic and Spatial Features Associated with Clinical Outcome
Shannon M. Liudahl, Courtney B. Betts, Shamilene Sivagnanam, et al.
Cancer Discovery (2021) Vol. 11, Iss. 8, pp. 2014-2031
Open Access | Times Cited: 123
Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment
Gregor Werba, Daniel Weissinger, Emily Kawaler, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 107
Exhaustion-associated cholesterol deficiency dampens the cytotoxic arm of antitumor immunity
Chengsong Yan, Lin Zheng, Shutan Jiang, et al.
Cancer Cell (2023) Vol. 41, Iss. 7, pp. 1276-1293.e11
Closed Access | Times Cited: 102
Tumor microbiome links cellular programs and immunity in pancreatic cancer
Bassel Ghaddar, Antara Biswas, Chris Harris, et al.
Cancer Cell (2022) Vol. 40, Iss. 10, pp. 1240-1253.e5
Open Access | Times Cited: 101
Context-Specific Determinants of the Immunosuppressive Tumor Microenvironment in Pancreatic Cancer
Chiara Falcomatà, Stefanie Bärthel, Günter Schneider, et al.
Cancer Discovery (2023) Vol. 13, Iss. 2, pp. 278-297
Open Access | Times Cited: 99
Epigenetic plasticity cooperates with cell-cell interactions to direct pancreatic tumorigenesis
Cassandra Burdziak, Direna Alonso‐Curbelo, Thomas Walle, et al.
Science (2023) Vol. 380, Iss. 6645
Open Access | Times Cited: 98
Multi-omic analyses of changes in the tumor microenvironment of pancreatic adenocarcinoma following neoadjuvant treatment with anti-PD-1 therapy
Keyu Li, Joseph A. Tandurella, Jessica Gai, et al.
Cancer Cell (2022) Vol. 40, Iss. 11, pp. 1374-1391.e7
Open Access | Times Cited: 94
Page 1 - Next Page

Scroll to top